Tag: Radiation
Addition of Metastasis-Directed Therapy Increases PFS in Prostate Cancer
Addition of MDT, consisting of radiation therapy, to hormone therapy results in improved progression-free survival
Breast-Conservation Therapy Feasible in Multiple Ipsilateral Breast Cancer
Estimated five-year cumulative incidence of local recurrence 3.1 percent for women undergoing BCT and adjuvant radiation
Initiating Salvage RT When PSA >0.25 ng/mL Linked to All-Cause Mortality
Risk for all-cause mortality up for men receiving post-radical prostatectomy salvage radiation therapy at PSA level >0.25 ng/mL
Causal Link Suggested Between High-Dose Radiation Exposure, CVD
Relative risk per Gy increased for all cardiovascular disease, but considerable interstudy variation noted
SBRT Well Tolerated, Effective for Primary Lung Neuroendocrine Tumor
At three, six, and nine years, overall survival was 64, 43, and 26 percent and progression-free survival was 88, 78, and 78 percent, respectively
Omission of Radiotherapy After Breast-Conserving Surgery Explored
Increased incidence of local recurrence seen with omission of radiotherapy, but no effect seen on overall survival
Patient-Reported Outcome Measure Developed for Radionuclide Therapy in Prostate Cancer
15-item measure deemed by key stakeholders to be relevant and useful in context of RNT for prostate cancer
Adjuvant Therapy Recommendations for Breast Cancer Drop Between Ages 69 and 70
Year-over-year age difference independent predictor for adjuvant radiation and endocrine therapy recommendations at age 70 versus 69 years
Female Cancer Survivors Experience Accelerated Declines in Physical Function
Physical function remains below that of age-matched controls even five years later
MRI-Guided Radiotherapy Bests CT Guidance for Prostate Cancer
Benefits seen for genitourinary and gastrointestinal toxic effects
